Search research articles
Contact Us
Filters
Showing results (41-50 of 72) with videos related to
Page
of 8
Sort By:
Intensive Care Medicine Experimental
|
May 3, 2021
Haptoglobin treatment prevents cell-free hemoglobin exacerbated mortality in experimental rat sepsis
Christian A Schaer, Victor Jeger, Thomas Gentinetta, et al.
Communications Biology
|
March 14, 2026
An ontogeny-cytokine code determines macrophage response polarity and tumor outcomes
Dominik J Schaer, Nadja Schulthess-Lutz, Matthias J Peterhans, et al.
Frontiers in Immunology
|
May 31, 2021
Acute Hemolysis and Heme Suppress Anti-CD40 Antibody-Induced Necro-Inflammatory Liver Disease
Marc Pfefferlé, Giada Ingoglia, Christian A Schaer, et al.
Pharmacology Research & Perspectives
|
April 4, 2018
Revisiting the putative role of heme as a trigger of inflammation
Florence Vallelian, Christian A Schaer, Jeremy W Deuel, et al.
Antioxidants & Redox Signaling
|
June 5, 2008
Structural stabilization in tetrameric or polymeric hemoglobin determines its interaction with endogenous antioxidant scavenger pathways
Paul W Buehler, Florence Vallelian, Malgorzata G Mikolajczyk, et al.
Antioxidants & Redox Signaling
|
August 26, 2009
Hemoglobin can attenuate hydrogen peroxide-induced oxidative stress by acting as an antioxidative peroxidase
Corinne C Widmer, Claudia P Pereira, Peter Gehrig, et al.
Journal of Proteome Research
|
March 17, 2011
Extracellular hemoglobin polarizes the macrophage proteome toward Hb-clearance, enhanced antioxidant capacity and suppressed HLA class 2 expression
Theresa Kaempfer, Elena Duerst, Peter Gehrig, et al.
The Journal of Clinical Investigation
|
December 7, 2023
Hemorrhage-activated NRF2 in tumor-associated macrophages drives cancer growth, invasion, and immunotherapy resistance
Dominik J Schaer, Nadja Schulthess-Lutz, Livio Baselgia, et al.
Journal for Immunotherapy of Cancer
|
November 1, 2025
Stress-NRF2 response axis polarizes tumor macrophages and undermines immunotherapy
Dominik J Schaer, Nadja Schulthess-Lutz, Livio Baselgia, et al.
Swiss Medical Weekly
|
March 11, 2019
Clinical outcomes in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: a retrospective analysis of results from the OBSErve study in Switzerland
Johannes von Kempis, Sabine Duetsch, Nicola Reuschling, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 72) with videos related to
Sort By:
Page
of 8
Intensive Care Medicine Experimental
|
May 3, 2021
Haptoglobin treatment prevents cell-free hemoglobin exacerbated mortality in experimental rat sepsis
Christian A Schaer, Victor Jeger, Thomas Gentinetta, et al.
Communications Biology
|
March 14, 2026
An ontogeny-cytokine code determines macrophage response polarity and tumor outcomes
Dominik J Schaer, Nadja Schulthess-Lutz, Matthias J Peterhans, et al.
Frontiers in Immunology
|
May 31, 2021
Acute Hemolysis and Heme Suppress Anti-CD40 Antibody-Induced Necro-Inflammatory Liver Disease
Marc Pfefferlé, Giada Ingoglia, Christian A Schaer, et al.
Pharmacology Research & Perspectives
|
April 4, 2018
Revisiting the putative role of heme as a trigger of inflammation
Florence Vallelian, Christian A Schaer, Jeremy W Deuel, et al.
Antioxidants & Redox Signaling
|
June 5, 2008
Structural stabilization in tetrameric or polymeric hemoglobin determines its interaction with endogenous antioxidant scavenger pathways
Paul W Buehler, Florence Vallelian, Malgorzata G Mikolajczyk, et al.
Antioxidants & Redox Signaling
|
August 26, 2009
Hemoglobin can attenuate hydrogen peroxide-induced oxidative stress by acting as an antioxidative peroxidase
Corinne C Widmer, Claudia P Pereira, Peter Gehrig, et al.
Journal of Proteome Research
|
March 17, 2011
Extracellular hemoglobin polarizes the macrophage proteome toward Hb-clearance, enhanced antioxidant capacity and suppressed HLA class 2 expression
Theresa Kaempfer, Elena Duerst, Peter Gehrig, et al.
The Journal of Clinical Investigation
|
December 7, 2023
Hemorrhage-activated NRF2 in tumor-associated macrophages drives cancer growth, invasion, and immunotherapy resistance
Dominik J Schaer, Nadja Schulthess-Lutz, Livio Baselgia, et al.
Journal for Immunotherapy of Cancer
|
November 1, 2025
Stress-NRF2 response axis polarizes tumor macrophages and undermines immunotherapy
Dominik J Schaer, Nadja Schulthess-Lutz, Livio Baselgia, et al.
Swiss Medical Weekly
|
March 11, 2019
Clinical outcomes in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: a retrospective analysis of results from the OBSErve study in Switzerland
Johannes von Kempis, Sabine Duetsch, Nicola Reuschling, et al.
Page
of 8